A Competitive Landscape: Key Players and Strategies in the Tislelizumab Injection Market
The global tislelizumab injection market is characterized by a dynamic competitive landscape, driven by rapid advancements in immunotherapy and the increasing demand for effective cancer treatments. Key players such as Takeda Pharmaceutical, Merck, and Novartis are at the forefront, each adopting distinct strategies to enhance their market presence. The market is characterized by significant...